DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 40 · July 2007 DOI: 10.1055/s-002-6939

Original Paper

  • 135
    Molina, V.; Reig, S.; Sanz, J.; Palomo, T.; Benito, C.; Sánchez, J.; Pascau, J.; Desco, M.:

    Changes in Cortical Volume with Olanzapine in Chronic Schizophrenia

  • 140
    Westheide, J.; Cohen, S.; Bender, S.; Cooper-Mahkorn, D.; Erfurth, A.; Gastpar, M.; Huber, T. J.; Maier, W.; Murafi, A.; Rothermund, M.; Signerski, J.; Sträter, B.; Teusch, L.; Weig, W.; Welling, A.; Kühn, K.-U.:

    Sexual Dysfunction in Psychiatric Inpatients The Role of Antipsychotic Medication

  • 146
    Drozdz, W.; Borkowska, A.; Wilkosc, M.; Halota, W.; Dybowska, D.; Rybakowski, J. K.:

    Chronic Paranoid Psychosis and Dementia Following Interferon-α Treatment of Hepatitis C: A Case Report

  • 149
    Schaefer, M.; Leopold, K.; Hinzpeter, A.; Heinz, A.; Krebs, M.:

    Memantine-associated Reversal of Clozapine-induced Weight Gain

  • 152
    Bandelow, B.; Stein, D. J.; Dolberg, O. T.; Andersen, H. F.; Baldwin, D. S.:

    Improvement of Quality of Life in Panic Disorder with Escitalopram, Citalopram, or Placebo

  • 157
    Molina, V.; Sanz, J.; Sarramea, F.; Palomo, T.:

    Marked Hypofrontality in Clozapine-responsive Patients

  • 163
    Bech, P.:

    Dose-response Relationship of Pregabalin in Patients with Generalized Anxiety Disorder. A Pooled Analysis of Four Placebo-controlled Trials

    • Letter

  • 169
    Baldaçara, L.; de Castro Ferrari, M. C.; Monteiro, B. F.; Uchida, R. R.; Sanches, M.:

    Hypomania Induced by Atypical Antipsychotics among Schizophrenic Patients: Report of Three Cases

  • 170
    Neuhaus, A. H.; Luborzewski, A.; Opgen-Rhein, C.; Jockers-Scherübl, M. C.; Neu, P.:

    Electroconvulsive Monotherapy in Confusion Psychosis: A Potential Standard Regimen?